Trial Outcomes & Findings for Rt-fMRI NF Intervention Study in ASD (NCT NCT02440451)

NCT ID: NCT02440451

Last Updated: 2019-02-20

Results Overview

The Emotion Hexagon test represents the primary outcome measure. The assessment based on this test will be performed before (baseline), after the intervention - endpoint 1 (at 8 weeks) and at the 6 months follow-up. The Emotion Hexagon test uses stimuli of graded difficulty, created using computer image manipulation techniques (morphing is used to modify photographs from the Ekman and Friesen (1976) series, creating examples that lie close to or more distant from the prototype expression). The 120 test trials with unambiguous stimuli (4 pictures for each of the 6 emotions across the 5 test blocks) can be used to derive an overall (total) score out of a possible maximum of 120 expressions correctly recognized.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

15 participants

Primary outcome timeframe

8 weeks (Endpoint 1) plus 6 months follow-up

Results posted on

2019-02-20

Participant Flow

The participants, mainly recruited on a collaborative effort between the Pediatrics Hospital of Coimbra and local ASD associations, were invited for an fMRI neurofeedback feasibility clinical trial study in ASD. All participants had normal or corrected to normal vision. ). The first participant was recruited in February 2016.

There was no significant events after participant enrollment, before group assignment.

Participant milestones

Participant milestones
Measure
Neurofeedback Using BCI
16 (13 + 3 in case of dropoffs) ASD subjects Neurofeedback (BCI using neuroimaging): This group will undergo five sessions of neurofeedback intervention in the fMRI scanner. Each subject will also undergo neuropsychological evaluations before the first neurofeedback session (week 0) and after the last neurofeedback session (week 7). The first four sessions are weekly while the last one is one month later. The intervention will take a total of four months. Follow up will be performed in the the first week and 6 months after the last intervention session.
Overall Study
STARTED
15
Overall Study
COMPLETED
15
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Rt-fMRI NF Intervention Study in ASD

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Neurofeedback Using BCI
n=15 Participants
16 (13 + 3 in case of dropoffs) ASD subjects Neurofeedback (BCI using neuroimaging): This group will undergo five sessions of neurofeedback intervention in the fMRI scanner. Each subject will also undergo neuropsychological evaluations before the first neurofeedback session (week 0) and after the last neurofeedback session (week 7). The first four sessions are weekly while the last one is one month later. The intervention will take a total of four months. Follow up will be performed in the the first week and 6 months after the last intervention session.
Age, Continuous
19.92 years
n=93 Participants
Sex: Female, Male
Female
0 Participants
n=93 Participants
Sex: Female, Male
Male
15 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
15 Participants
n=93 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=93 Participants
Race (NIH/OMB)
Asian
0 Participants
n=93 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=93 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=93 Participants
Race (NIH/OMB)
White
15 Participants
n=93 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=93 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants
Region of Enrollment
Portugal
15 Participants
n=93 Participants
FEEST - Facial Expression of Emotion: Stimuli and Tests
98 units on a scale
STANDARD_DEVIATION 19.30 • n=93 Participants
ATEC - Autism Treatment Evaluation Checklist
36.6 units on a scale
STANDARD_DEVIATION 13.94 • n=93 Participants
VABS - Vineland Adaptive Behaviour Scale
Baseline [VABS COM]
70.6 units on a scale
STANDARD_DEVIATION 15.65 • n=93 Participants
VABS - Vineland Adaptive Behaviour Scale
Baseline [VABS DLS]
74 units on a scale
STANDARD_DEVIATION 17.15 • n=93 Participants
VABS - Vineland Adaptive Behaviour Scale
Baseline [VABS SOC]
63.4 units on a scale
STANDARD_DEVIATION 14.21 • n=93 Participants
VABS - Vineland Adaptive Behaviour Scale
Baseline [VABS ABC]
63.4 units on a scale
STANDARD_DEVIATION 13.52 • n=93 Participants

PRIMARY outcome

Timeframe: 8 weeks (Endpoint 1) plus 6 months follow-up

The Emotion Hexagon test represents the primary outcome measure. The assessment based on this test will be performed before (baseline), after the intervention - endpoint 1 (at 8 weeks) and at the 6 months follow-up. The Emotion Hexagon test uses stimuli of graded difficulty, created using computer image manipulation techniques (morphing is used to modify photographs from the Ekman and Friesen (1976) series, creating examples that lie close to or more distant from the prototype expression). The 120 test trials with unambiguous stimuli (4 pictures for each of the 6 emotions across the 5 test blocks) can be used to derive an overall (total) score out of a possible maximum of 120 expressions correctly recognized.

Outcome measures

Outcome measures
Measure
Neurofeedback Using BCI
n=15 Participants
16 (13 + 3 in case of dropoffs) ASD subjects Neurofeedback (BCI using neuroimaging): This group will undergo five sessions of neurofeedback intervention in the fMRI scanner. Each subject will also undergo neuropsychological evaluations before the first neurofeedback session (week 0) and after the last neurofeedback session (week 7). The first four sessions are weekly while the last one is one month later. The intervention will take a total of four months. Follow up will be performed in the the first week and 6 months after the last intervention session.
FEEST - Facial Expression of Emotion: Stimuli and Tests
6 months follow-up
100.79 units on a scale
Standard Deviation 20.01
FEEST - Facial Expression of Emotion: Stimuli and Tests
Endpoint 1
100.27 units on a scale
Standard Deviation 19.29

SECONDARY outcome

Timeframe: 8 weeks (Endpoint 1) plus 6 months follow up

Autism Treatment Evaluation Checklist (ATEC) evaluates the effectiveness of autism treatments - a 1-page form designed to be completed by parents or caretakers. It consists of 4 subtests: I. Speech/Language Communication (14 items, min.0-max.28); II. Sociability (20 items, min.0-max.40); III. Sensory/Cognitive Awareness (18 items, min.0-max.36); and IV. Health/Phys./Behavior (25 items, min.0-max.75). Total score (sum) ranges from min.0-max.179. The results reported here correspond to the total ATEC score to be used for comparison at a later date. The lower the score, the fewer the problems.

Outcome measures

Outcome measures
Measure
Neurofeedback Using BCI
n=15 Participants
16 (13 + 3 in case of dropoffs) ASD subjects Neurofeedback (BCI using neuroimaging): This group will undergo five sessions of neurofeedback intervention in the fMRI scanner. Each subject will also undergo neuropsychological evaluations before the first neurofeedback session (week 0) and after the last neurofeedback session (week 7). The first four sessions are weekly while the last one is one month later. The intervention will take a total of four months. Follow up will be performed in the the first week and 6 months after the last intervention session.
ATEC - Autism Treatment Evaluation Checklist
Endpoint 1
32 units on a scale
Standard Deviation 14.66
ATEC - Autism Treatment Evaluation Checklist
6 months follow-up
19.64 units on a scale
Standard Deviation 8.13

SECONDARY outcome

Timeframe: 8 weeks (Endpoint 1) plus 6 months follow-up

The Vineland Adaptive Behaviour Scale (VABS) is a semi-structured interview designed to assess global adaptive functioning, composed by 3 main domains: Communication COM, Daily Living Skills DLS and Socialization SOC (all reported here in terms of standard scores as described in the VABS manual, i.e. mean 100 and standard deviation 15). The Adaptive Behaviour Composite ABC (total score, also reported here) is the sum of the raw scores from the three main domains. These are transformed in standard scores (m.=100;std.=15). The higher the score, better is the adaptive behavior.

Outcome measures

Outcome measures
Measure
Neurofeedback Using BCI
n=15 Participants
16 (13 + 3 in case of dropoffs) ASD subjects Neurofeedback (BCI using neuroimaging): This group will undergo five sessions of neurofeedback intervention in the fMRI scanner. Each subject will also undergo neuropsychological evaluations before the first neurofeedback session (week 0) and after the last neurofeedback session (week 7). The first four sessions are weekly while the last one is one month later. The intervention will take a total of four months. Follow up will be performed in the the first week and 6 months after the last intervention session.
VABS - Vineland Adaptive Behaviour Scale
Endpoint 1 [VABS COM]
74.87 units on a scale
Standard Deviation 14.95
VABS - Vineland Adaptive Behaviour Scale
6 months follow-up [VABS COM]
79.79 units on a scale
Standard Deviation 13.69
VABS - Vineland Adaptive Behaviour Scale
6 months follow-up [VABS DLS]
83.14 units on a scale
Standard Deviation 17.00
VABS - Vineland Adaptive Behaviour Scale
Endpoint 1 [VABS DLS]
76.93 units on a scale
Standard Deviation 16.46
VABS - Vineland Adaptive Behaviour Scale
Endpoint 1 [VABS SOC]
66.73 units on a scale
Standard Deviation 16.42
VABS - Vineland Adaptive Behaviour Scale
Endpoint 1 [VABS ABC]
67.13 units on a scale
Standard Deviation 15.22
VABS - Vineland Adaptive Behaviour Scale
6 months follow-up [VABS SOC]
71.43 units on a scale
Standard Deviation 15.36
VABS - Vineland Adaptive Behaviour Scale
6 months follow-up [VABS ABC]
73.57 units on a scale
Standard Deviation 13.67

OTHER_PRE_SPECIFIED outcome

Timeframe: 8 weeks (Endpoint 1) plus 6 months follow-up

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 8 weeks (Endpoint 1) plus 6 months follow-up

24-item scale (7 depression \& 7 anxiety items)

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 8 weeks (Endpoint 1) plus 6 months follow-up

21-item measure of clinical depression

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 8 weeks (Endpoint 1)

Covers: strategies; general experience of the process; adverse effects;

Outcome measures

Outcome data not reported

Adverse Events

Neurofeedback Using BCI

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Prof. Dr. Miguel Castelo-Branco

University of Coimbra

Phone: +351239790000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place